Hemp is considered to be the equivalent of cannabis in the Philippines and is, therefore, a prohibited drug, carrying severe penalties for its cultivation, manufacture, sale, importation, possession and use under Republic Act No. 9165, known as the Comprehensive Dangerous Drugs Act of 2002.
Although there are some exceptions regarding hemp imports (i.e. for medical use and in some processed forms), its sale is minimal, according to a report issued by the USDA Foreign Agricultural Service. A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the country.
Table of Contents
1 Executive Summary
2 Outlook
3 Hemp Plant
4 Extracts as a Finished Product
5 Finished Products Containing CBD and Extracts
6 Import and Export Requirements
7 Medical Cannabis
8 Recreational Cannabis
9 Relevant Laws
10 Relevant Bodies
Methodology
General Methodology/Sources
- Consumer and market participant (manufacturer/brand) surveys.
- Consolidation of publicly available information.
- Legal tracking through legal database checking and sourcing information from government regulators and other law-making bodies.
- Pricing and product information from online and offline retail data gathering, including local fieldwork teams.
- Findings from key industry events and interviews with leading market players and opinion leaders.
- Partnerships with leading research agencies.
- Quantitative and qualitative research and client collaborations.
- Cross-referenced data between markets.
- Tamarind Media proprietary market model.
Please note that each report has its own methodology, so you should always refer to the methodology applied in the report you purchase.
LOADING...
